Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer

被引：0
|
作者：
Mariangela Manzoni
Sara Mariucci
Sara Delfanti
Bianca Rovati
Monica Ronzoni
Fotios Loupakis
Silvia Brugnatelli
Carmine Tinelli
Eugenio Villa
Alfredo Falcone
Marco Danova
机构：
[1] Fondazione IRCCS Policlinico S. Matteo,S.C. Oncologia
[2] Istituto Scientifico S. Raffaele,Oncologia Medica
[3] Oncologia 2 Universitaria,Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologie in Medicina
[4] Azienda Ospedaliero-Universitaria Pisana,Unità di Epidemiologia Clinica e Biometria
[5] Fondazione IRCCS Policlinico S. Matteo,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词：
Biomarkers; Circulating endothelial cells; Apoptosis; Angiogenesis; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1187 / 1196
页数：9
相关论文
共 50 条
  • [31] Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation
    Janku, Filip
    Wheler, Jennifer J.
    Hong, David S.
    Kurzrock, Razelle
    TARGETED ONCOLOGY, 2013, 8 (03) : 183 - 188
  • [32] Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation
    Filip Janku
    Jennifer J. Wheler
    David S. Hong
    Razelle Kurzrock
    Targeted Oncology, 2013, 8 : 183 - 188
  • [33] Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer
    Lim, S. H.
    Becker, T. M.
    Chua, W.
    Caixeiro, N. J.
    Ng, W. L.
    Kienzle, N.
    Tognela, A.
    Lumba, S.
    Rasko, J. E. J.
    de Souza, P.
    Spring, K. J.
    CANCER LETTERS, 2014, 346 (01) : 24 - 33
  • [34] Practical Utility of Circulating Tumour Cells as Biomarkers in Cancer Chemotherapy for Advanced Colorectal Cancer
    Otsuka, Kazunori
    Imai, Hiroo
    Soeda, Hiroshi
    Komine, Keigo
    Ishioka, Chikashi
    Shibata, Hiroyuki
    ANTICANCER RESEARCH, 2013, 33 (02) : 625 - 629
  • [35] Predictive value of VEGF gene polymorphisms in metastatic colorectal cancer patients treated with a bevacizumab-based chemotherapy.
    Ulivi, Paola
    Marisi, Giorgia
    Scarpi, Emanuela
    Passardi, Alessandro
    Ragazzini, Angela
    Frassineti, Giovanni Luca
    Zoli, Wainer
    Valgiusti, Martina
    Nanni, Oriana
    Calistri, Daniele
    Casacci, Fabio
    Amadori, Dino
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] NEW IMAGING AND MOLECULAR BIOMARKERS TO PREDICT PATHOLOGICAL RESPONSE TO BEVACIZUMAB-BASED TREATMENT IN NEOADJUVANT BREAST CANCER
    Garcia-Foncillas, J.
    Plazaola, A.
    Hernando, B.
    Sanchez, R.
    Alvarez, I.
    Anton, A.
    Martinez Del Prado, P.
    Llombart, A.
    Sherer, S.
    Lopez-Vega, J. M.
    ANNALS OF ONCOLOGY, 2012, 23 : 82 - 83
  • [37] CD276-positive circulating endothelial cells in advanced colorectal cancer
    Gootjes, Elske C.
    Kraan, Jaco
    Buffart, Tineke
    Verhoef, Cornelis
    Verheul, Henk M. W.
    Sleijfer, Stefan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [38] Sequential Bevacizumab-based therapy in metastatic colorectal cancer (mCRC): results of a treatment sequencing cost analysis
    Rautenberg, T.
    Siebert, U.
    Arnold, D.
    Bennouna, J.
    Kubicka, S.
    Walzer, S.
    Ngoh, C.
    ONKOLOGIE, 2012, 35 : 56 - 56
  • [39] Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer
    Beibei Chen
    Huan Zhao
    Huihui Hu
    Haili Shang
    Hui Wang
    Zhentao Yao
    Jinxi Huang
    Huifang Lv
    Weifeng Xu
    Jianzheng Wang
    Caiyun Nie
    Jing Zhao
    Yunduan He
    Saiqi Wang
    Xiaobing Chen
    Scientific Reports, 15 (1)
  • [40] Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer
    Prager, Gerald W.
    Braemswig, Kira H.
    Martel, Alexandra
    Unseld, Matthias
    Heinze, Georg
    Brodowicz, Thomas
    Scheithauer, Werner
    Kornek, Gabriela
    Zielinski, Christoph C.
    CANCER SCIENCE, 2014, 105 (08) : 996 - 1001
12345